CASAMENTO CHARLES J
Insider CIK 1117167 · GTBP Director · ISCO.OB Director · RLMD Director · AZRX Director · ETON Director · PXMD Director · COR Director · VVUS Director · ASTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-07-31 | 2026-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 7,757 | — | $0 | 302,928 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2026-01-12 | 2026-01-14 | 12,196 | — | $0 | 295,171 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-12-12 | 2025-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| GTBP GT Biopharma, Inc. | A Award deriv | 2025-09-04 | 2025-09-08 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-06-26 | 2025-06-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | G Gift | 2024-10-22 | 2024-10-23 | 13,000 | — | $0 | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-09 | 2024-09-11 | 13,000 | $2.56 | $33.3K | 13,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | J Other deriv | 2024-05-24 | 2024-05-29 | 20,976 | — | $0 | 31,522 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2024-05-24 | 2024-05-29 | 20,976 | — | $0 | 52,498 | SEC↗ |
| PXMD PaxMedica, Inc. | F Tax w/h | 2024-03-12 | 2024-03-14 | 992 | $0.69 | $684 | 2,386 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 30,000 | — | $0 | 164,555 | SEC↗ |
| PXMD PaxMedica, Inc. | F Tax w/h | 2024-01-29 | 2024-01-31 | 97 | $0.76 | $74 | 3,378 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | A Award | 2024-01-02 | 2024-01-04 | 19,633 | — | $0 | 19,937 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-12-15 | 2023-12-19 | 31,522 | — | $0 | 31,522 | SEC↗ |
| PXMD PaxMedica, Inc. | F Tax w/h | 2023-10-02 | 2023-10-04 | 6,536 | $0.29 | $1.9K | 59,047 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | S Sale | 2023-09-15 | 2023-09-18 | 10 | $0.43 | $4 | 6,098 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | S Sale | 2023-08-31 | 2023-09-05 | 6,053 | $0.30 | $1.8K | 6,108 | SEC↗ |
| GTBP GT Biopharma, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 92,958 | — | $0 | 150,000 | SEC↗ |
| PXMD PaxMedica, Inc. | A Award | 2023-04-13 | 2023-04-14 | 14,000 | — | $0 | 65,583 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2023-03-03 | 2023-03-03 | 25,000 | — | $0 | 134,555 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | A Award | 2023-01-03 | 2023-01-05 | 84,745 | — | $0 | 85,134 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-12-16 | 2022-12-20 | 57,042 | — | $0 | 57,042 | SEC↗ |
| PXMD PaxMedica, Inc. | A Award | 2022-10-01 | 2022-10-04 | 51,583 | — | $0 | 51,583 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 91,235 | — | $0 | 150,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2022-04-01 | 2022-04-05 | 19,800 | — | $0 | 77,511 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 13,200 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 16,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 9,900 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 6,600 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 3,300 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2022-04-01 | 2022-04-05 | 3,300 | $29.00 | $95.7K | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2022-04-01 | 2022-04-05 | 19,800 | $3.24 | $64.2K | 19,800 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2022-02-07 | 2022-02-28 | 50,000 | — | $0 | 109,555 | SEC↗ |
| FWBI First Wave BioPharma, Inc. | A Award deriv | 2022-01-03 | 2022-01-03 | 34,482 | — | $0 | 34,482 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-12-17 | 2021-12-21 | 58,765 | — | $0 | 58,765 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-09-22 | 2021-09-24 | 1,900 | — | $0 | 97,311 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-09-22 | 2021-09-24 | 10,000 | $4.60 | $46.0K | 16,600 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-09-22 | 2021-09-24 | 1,900 | $29.00 | $55.1K | 14,700 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-09-22 | 2021-09-24 | 3,300 | $29.00 | $95.7K | 11,400 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-09-22 | 2021-09-24 | 1,400 | $29.00 | $40.6K | 10,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-08-17 | 2021-08-19 | 10,000 | — | $0 | 102,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-08-17 | 2021-08-19 | 10,000 | $4.60 | $46.0K | 14,700 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-07-15 | 2021-07-16 | 2,136 | $31.03 | $66.3K | 5,854 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-07-15 | 2021-07-16 | 1,164 | $32.49 | $37.8K | 4,700 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-06-01 | 2021-06-02 | 2,480 | $33.19 | $82.3K | 6,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-06-01 | 2021-06-02 | 520 | $34.08 | $17.7K | 9,430 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 19,655 | — | $0 | 59,555 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-05-03 | 2021-05-05 | 3,000 | $38.22 | $114.7K | 9,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-04-01 | 2021-04-05 | 1,691 | $35.04 | $59.3K | 12,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-04-01 | 2021-04-05 | 1,309 | $35.93 | $47.0K | 14,641 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-01 | 2021-03-02 | 3,000 | $33.87 | $101.6K | 15,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-01 | 2021-02-02 | 1,663 | $33.90 | $56.4K | 18,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-01 | 2021-02-02 | 1,337 | $33.30 | $44.5K | 20,613 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 41,237 | — | $0 | 41,237 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-04 | 2021-01-05 | 3,000 | $32.11 | $96.3K | 21,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-12-01 | 2020-12-02 | 3,000 | $35.74 | $107.2K | 24,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | G Gift | 2020-11-24 | 2020-12-02 | 21,223 | — | $0 | 27,950 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-11-02 | 2020-11-03 | 3,000 | $30.29 | $90.9K | 49,173 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-10-01 | 2020-10-02 | 3,000 | $37.99 | $114.0K | 52,173 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-09-01 | 2020-09-02 | 3,000 | $34.74 | $104.2K | 55,173 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2020-08-18 | 2020-08-19 | 26,362 | — | $0 | 33,404 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2020-08-18 | 2020-08-19 | 26,362 | $3.24 | $85.4K | 60,362 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | F Tax w/h | 2020-08-18 | 2020-08-19 | 2,189 | $39.03 | $85.4K | 58,173 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-08-03 | 2020-08-04 | 3,000 | $35.74 | $107.2K | 34,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2020-07-01 | 2020-07-02 | 3,000 | $43.89 | $131.7K | 37,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2020-04-06 | 2020-04-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | G Gift | 2020-03-19 | 2020-03-23 | 9,000 | — | $0 | 116,998 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | G Gift | 2020-03-19 | 2020-03-23 | 9,000 | — | $0 | 107,998 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | G Gift | 2020-03-17 | 2020-03-18 | 21,484 | — | $0 | 40,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | G Gift | 2020-03-17 | 2020-03-18 | 21,484 | — | $0 | 21,484 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2020-03-12 | 2020-03-16 | 27,400 | — | $0 | 27,400 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2020-03-11 | 2020-03-13 | 14,584 | $0.60 | $8.8K | 108,584 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2020-03-11 | 2020-03-13 | 8,414 | $1.04 | $8.8K | 116,998 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2019-12-31 | 2020-01-03 | 7,500 | $1.04 | $7.8K | 94,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2019-12-24 | 2019-12-27 | 21,094 | — | $0 | 91,406 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2019-12-24 | 2019-12-27 | 46,484 | — | $0 | 59,766 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2019-12-24 | 2019-12-27 | 46,484 | $3.24 | $150.6K | 46,484 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2019-12-24 | 2019-12-27 | 21,094 | $4.60 | $97.0K | 67,578 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | F Tax w/h | 2019-12-24 | 2019-12-27 | 3,706 | $40.64 | $150.6K | 63,872 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | F Tax w/h | 2019-12-24 | 2019-12-27 | 2,388 | $40.64 | $97.0K | 61,484 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-12-19 | 2019-12-23 | 100,000 | $43.47 | $4.35M | 100,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2019-09-30 | 2019-10-01 | 7,500 | $0.60 | $4.5K | 86,500 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2019-08-09 | 2019-08-12 | 3,500 | $6.11 | $21.4K | 71,920 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-07-29 | 2019-07-30 | 500,000 | $2.20 | $1.10M | 500,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2019-06-30 | 2019-07-02 | 7,500 | $1.70 | $12.8K | 79,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2019-06-13 | 2019-06-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2019-06-13 | 2019-06-17 | 30,000 | — | $0 | 101,500 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2019-03-31 | 2019-04-29 | 7,500 | $2.42 | $18.1K | 71,500 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | A Award deriv | 2019-02-20 | 2019-03-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | P Buy | 2018-12-28 | 2019-01-02 | 9,000 | $1.41 | $12.7K | 56,500 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2018-12-28 | 2019-01-02 | 7,500 | $1.29 | $9.7K | 64,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2018-12-20 | 2018-12-20 | 450,000 | $1.15 | $517.5K | 450,000 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | C Conversion deriv | 2018-11-15 | 2018-11-15 | 8,000 | — | $0 | 0 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | C Conversion | 2018-11-15 | 2018-11-15 | 8,675 | — | $0 | 63,420 | SEC↗ |
| ETON Eton Pharmaceuticals, Inc. | P Buy | 2018-11-15 | 2018-11-15 | 5,000 | $6.00 | $30.0K | 68,420 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2018-09-28 | 2018-10-01 | 7,500 | $2.57 | $19.3K | 47,500 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2018-06-29 | 2018-07-16 | 7,500 | — | $0 | 40,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2018-06-21 | 2018-06-25 | 4,328 | — | $0 | 14,431 | SEC↗ |
| ISCO.OB International Stem Cell CO | G Gift | 2018-05-16 | 2018-05-16 | 12,280 | — | $0 | 10,103 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2018-03-30 | 2018-04-04 | 5,527 | — | $0 | 22,383 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2018-03-29 | 2018-04-02 | 7,500 | $3.14 | $23.6K | 32,500 | SEC↗ |
| ISCO.OB International Stem Cell CO | G Gift | 2018-01-09 | 2018-02-01 | 34,000 | — | $0 | 16,856 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2017-12-29 | 2018-01-02 | 5,175 | — | $0 | 50,856 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2017-10-20 | 2017-10-23 | 425,000 | $0.81 | $344.3K | 425,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2017-10-19 | 2017-10-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2017-09-29 | 2017-10-02 | 4,415 | — | $0 | 45,681 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2017-06-30 | 2017-07-05 | 7,127 | — | $0 | 41,266 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2017-05-31 | 2017-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2017-03-31 | 2017-04-03 | 4,642 | — | $0 | 34,139 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-12-30 | 2016-12-30 | 7,523 | — | $0 | 29,497 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-10-13 | 2016-10-14 | 1,334 | — | $0 | 21,974 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-09-30 | 2016-09-30 | 4,391 | — | $0 | 20,640 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-06-30 | 2016-06-30 | 4,042 | — | $0 | 16,249 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award deriv | 2016-05-17 | 2016-05-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2016-03-31 | 2016-04-04 | 2,104 | — | $0 | 12,207 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-12-31 | 2015-12-31 | 2,403 | — | $0 | 10,103 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 300 | $2.90 | $870 | 3,300 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 400 | $2.98 | $1.2K | 4,200 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 1,700 | $2.98 | $5.1K | 1,700 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 500 | $2.95 | $1.5K | 3,800 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 1,300 | $2.97 | $3.9K | 3,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-09-30 | 2015-10-02 | 2,011 | — | $0 | 7,700 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2015-06-30 | 2015-07-02 | 181,767 | — | $0 | 853,344 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2015-04-08 | 2015-04-08 | 99,946 | — | $0 | 671,577 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2015-03-06 | 2015-03-23 | 76,958 | — | $0 | 571,611 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2014-10-02 | 2014-10-02 | 49,653 | — | $0 | 494,653 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2014-05-08 | 2014-05-12 | 40,000 | — | $0 | 445,000 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2014-03-21 | 2014-03-25 | 162,500 | — | $0 | 405,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 15,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 10,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 15,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 833 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 25,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 35,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 7,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 20,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 20,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-01 | 2013-10-16 | 32,500 | — | $0 | 0 | SEC↗ |
| ISCO International Stem Cell CO | A Award | 2013-06-20 | 2013-06-21 | 40,000 | — | $0 | 242,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2013-06-13 | 2013-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2013-06-13 | 2013-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-03 | 2013-05-07 | 20,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-03 | 2013-05-07 | 12,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-03 | 2013-05-07 | 21,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-03 | 2013-05-07 | 10,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-05-03 | 2013-05-07 | 7,500 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-05-03 | 2013-05-07 | 32,500 | $2.10 | $68.3K | 71,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-05-03 | 2013-05-07 | 5,500 | $5.91 | $32.5K | 65,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-05-03 | 2013-05-07 | 65,500 | $5.87 | $384.5K | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-05-03 | 2013-05-07 | 10,000 | $2.01 | $20.1K | 38,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-05-03 | 2013-05-07 | 28,500 | $4.03 | $114.9K | 28,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | G Gift | 2013-04-12 | 2013-04-16 | 30,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-04-03 | 2013-04-05 | 10,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-04-03 | 2013-04-05 | 10,000 | $2.01 | $20.1K | 30,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-04-02 | 2013-04-03 | 10,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-04-02 | 2013-04-03 | 10,000 | $1.98 | $19.8K | 20,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-03-28 | 2013-03-29 | 10,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-03-28 | 2013-03-29 | 10,000 | $1.98 | $19.8K | 10,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2013-03-13 | 2013-03-15 | 14,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2013-03-13 | 2013-03-15 | 14,000 | $2.46 | $34.4K | 14,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | S Sale | 2013-03-13 | 2013-03-15 | 14,000 | $4.27 | $59.8K | 0 | SEC↗ |
| VVUS VIVUS INC | A Award | 2013-01-25 | 2013-01-29 | 21,125 | — | $0 | 87,125 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2013-01-25 | 2013-01-29 | 162,500 | — | $0 | 202,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | G Gift | 2012-09-17 | 2013-02-21 | 50,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2012-09-06 | 2012-09-10 | 25,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise deriv | 2012-09-06 | 2012-09-10 | 25,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2012-09-06 | 2012-09-10 | 25,000 | $2.76 | $69.0K | 25,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | M Exercise | 2012-09-06 | 2012-09-10 | 25,000 | $2.76 | $69.0K | 50,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-08-20 | 2012-08-21 | 8,000 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-08-20 | 2012-08-21 | 8,000 | $5.69 | $45.5K | 74,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-08-20 | 2012-08-21 | 8,000 | $20.63 | $165.0K | 66,000 | SEC↗ |
| COR CORTEX PHARMACEUTICALS INC | A Award deriv | 2012-08-03 | 2012-08-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| COR CORTEX PHARMACEUTICALS INC | A Award deriv | 2012-08-03 | 2012-08-07 | 346,667 | — | $0 | 376,667 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-06-22 | 2012-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-06-22 | 2012-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VVUS VIVUS INC | A Award | 2012-06-15 | 2012-06-19 | 5,000 | — | $0 | 66,000 | SEC↗ |
| ISCO.OB International Stem Cell CO | A Award | 2012-05-29 | 2012-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VVUS VIVUS INC | G Gift | 2012-04-05 | 2013-04-22 | 36,000 | — | $0 | 26,125 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-03-12 | 2012-03-13 | 25,000 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-03-12 | 2012-03-13 | 8,000 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-03-12 | 2012-03-13 | 4,000 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-03-12 | 2012-03-13 | 4,000 | $20.14 | $80.6K | 61,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-03-12 | 2012-03-13 | 4,000 | $7.67 | $30.7K | 65,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-03-12 | 2012-03-13 | 25,000 | $20.14 | $503.5K | 61,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-03-12 | 2012-03-13 | 8,000 | $9.91 | $79.3K | 69,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-03-12 | 2012-03-13 | 8,000 | $20.14 | $161.1K | 61,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-03-12 | 2012-03-13 | 25,000 | $8.74 | $218.5K | 86,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-28 | 8,000 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-28 | 4,000 | — | $0 | 4,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-28 | 24,000 | — | $0 | 8,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-28 | 24,000 | $5.69 | $136.6K | 61,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-28 | 8,000 | $6.10 | $48.8K | 33,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-28 | 4,000 | $7.67 | $30.7K | 37,000 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2012-01-27 | 2012-01-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VVUS VIVUS INC | G Gift | 2011-12-14 | 2013-04-22 | 25,000 | — | $0 | 62,125 | SEC↗ |